Dergiler / Fabad Eczacılık Bilimler Dergisi / 2026 / Cilt: 50 Sayı: 1

FORMULATION AND CHARACTERIZATION OF LIQUISOLID TABLETS FOR IMPROVING DISSOLUTION OF TELMISARTAN

Dr Chinmaya Keshari Sahoo(College of Pharmaceutical Sciences, Puri)0000-0003-4290-4828
Nidhi Shree(College of Pharmaceutical Sciences, Puri)0009-0009-1490-4485
Amiyakanta Mishra(College of Pharmaceutical Sciences, Puri)0000-0002-5769-781X
Sayfa
51–64
Yayın Tarihi
2025-03-25
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

After three months of storage, there was no discernible change in the tablet's characteristics or the drug release profile.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The current study's objective was to create liquisolid tablets (LST) in order to improve the dissolution profile of telmisartan, a poorly soluble medication (BCS class II).
📊
Temel Bulgular & Veri:To prepare LST, the following ingredients were used: microcrystalline cellulose (MCC) as the carrier, PEG as the vehicle, croscarmelose sodium (CCS) as the superdisintegrant, and Aerosil 200 as the coating material.
💡
Sonuç & Katkı:After three months of storage, there was no discernible change in the tablet's characteristics or the drug release profile.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:BCS · LST · Dissolution

Abstract

The current study's objective was to create liquisolid tablets (LST) in order to improve the dissolution profile of telmisartan, a poorly soluble medication (BCS class II). To prepare LST, the following ingredients were used: microcrystalline cellulose (MCC) as the carrier, PEG as the vehicle, croscarmelose sodium (CCS) as the superdisintegrant, and Aerosil 200 as the coating material. The tablet quality control tests, flow characteristics, and interactions between the medication and excipient were assessed for each formulation. Higuchi, Korsmeyer-Peppas, zero order, and first order pharmacokinetic models were used to examine the in vitro drug release (IVDR) kinetics for various batches. When the optimized formulation was evaluated for stability at 75±5% RH and 40±2ºC, it was shown to be stable for up to three months. No interaction between the medication and excipients was confirmed by Fourier Transform Infrared Spectroscopy (FTIR) investigations. The solubility studies were used to guide the selection of dissolution medium. Comparing the optimized formulation (TC3) to the traditional marketed formulation (TELVAS 20), a notable improvement in dissolution was observed. After three months of storage, there was no discernible change in the tablet's characteristics or the drug release profile.

🔖

Bu Makaleye Atıf Yap

Sahoo, D. C. K., Shree, N., Mishra, A. (2025). FORMULATION AND CHARACTERIZATION OF LIQUISOLID TABLETS FOR IMPROVING DISSOLUTION OF TELMISARTAN. Fabad Eczacılık Bilimler Dergisi, Cilt: 50 Sayı: 1, 51–64. https://doi.org/10.55262/fabadeczacilik.1518230

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Barzegar, JM., Javadzadeh, Y., Nokhodchi, A., Siahi- Shadbad, MR. (2005). Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il Farmaco, 60(4), 361-365.